Command Palette

Search for a command to run...

Clinical Trials · NCT00978393

A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

CompletedPhase 1Liraglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
49
Start date
Sep 2009
Locations
1 site, Netherlands
Primary endpoint
Gastric emptying measured as AUC0-300min of paracetamol postprandial concentration profiles during a standardised meal test with intake of 1.5 g paracetamol
View Liraglutide compound reference